Guru Ownership Trend
Guru Analysis for Vertex Pharmaceuticals Incorporated (VRTX)
Vertex Pharmaceuticals Incorporated (VRTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 10 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $583.92 M.
Top institutional holders include Renaissance Technologies and Manning & Napier Group.
Institutional sentiment is currently Bearish. This is evidenced by a $153.4 M net outflow during the quarter.
Recent activity highlights Jefferies Group who increased their stake by 96.1%. Conversely, Paul Tudor Jones reduced exposure by 89.0%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Vertex Pharmaceuticals Incorporated (VRTX)
Major holders include Renaissance Technologies ($228.97 M), Manning & Napier Group ($194.02 M), Cliff Asness ($65.13 M). According to the latest reported data, 10 tracked investment managers collectively hold approximately 1.25 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $153.4 M, with 3 managers increasing positions and 8 managers reducing holdings.
During the most recent reporting period, 7 managers trimmed their positions, while 1 fully exited VRTX. The total reported sell value was $160.61 M.
Yes, 0 managers opened new positions in VRTX, and 3 increased their existing holdings. The total reported buy value was $7.2 M.
